Neurocrine Bioscience buy Needham & Company LLC
Start price
15.04.25
/
50%
€86.30
Target price
15.04.26
€121.87
Performance (%)
27.81%
End price
16.04.26
€110.30
Summary
This prediction ended on 16.04.26 with a price of €110.30. The prediction had a final performance of 27.81%. Needham___Company_LL has a follow-up prediction for Neurocrine Bioscience where he still thinks Neurocrine Bioscience is a Buy. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | -6.832% | -6.832% | 29.699% |
| iShares Core DAX® | 2.334% | 1.011% | 10.406% |
| iShares Nasdaq 100 | 1.370% | -3.612% | 27.400% |
| iShares Nikkei 225® | 2.437% | -7.461% | 49.840% |
| iShares S&P 500 | 1.259% | 0.677% | 23.666% |
Comments by Needham___Company_LL for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $138.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten
Current prediction by Needham___Company_LL for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.40
22.09.25
22.09.25
€144.89
22.09.26
22.09.26
15.76%
04.08.26
04.08.26
Stopped prediction by Needham___Company_LL for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€148.60
31.07.26
31.07.26
€177.24
31.07.27
31.07.27
-3.10%
04.08.26
04.08.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€113.60
06.04.26
06.04.26
€160.60
06.04.27
06.04.27
26.19%
04.08.26
04.08.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.35
06.05.25
06.05.25
€123.07
06.05.26
06.05.26
10.28%
07.05.26
07.05.26